Citigroup
SGRX

Citigroup’s SANGRIX INC. Class A Ordinary Shares SGRX Stock Holding History

Citigroup’s Portfolio SGRX Stock Details SGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6
Closed -$328 – 5974
2025
Q4 		$328 Buy
+6
New +$559 ﹤0.01% 5617
2025
Q2 		– Sell
-1
Closed -$29 – 5667
2025
Q1 		$29 Buy
+1
New +$144 ﹤0.01% 5465
2022
Q2 		– Sell
-2
Closed -$15K – 6255
2022
Q1 		$15K Buy
+2
New +$20.1K ﹤0.01% 5309

Other funds holding SGRX

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CFP
Comprehensive Financial Planning East Petersburg, Pennsylvania $188M AUM 48.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Citigroup's SGRX Position: Q1 2026 in Review

Citigroup sold out of SANGRIX INC. Class A Ordinary Shares (SGRX) in Q1 2026, closing a stake of 6 shares — an estimated $328 sold.

Citigroup first reported a position in SGRX in Q1 2022 and held it in 3 quarters. The position peaked at $15K in Q1 2022. 4 funds tracked by Wall St. Rank hold SGRX as of Q1 2026.

  • Citigroup reported no remaining SANGRIX INC. Class A Ordinary Shares position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 6 SANGRIX INC. Class A Ordinary Shares shares in Q1 2026, an estimated $328.
  • Citigroup first reported a position in SANGRIX INC. Class A Ordinary Shares in Q1 2022 and held it in 3 quarters.
  • Citigroup's SANGRIX INC. Class A Ordinary Shares position peaked at $15K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held SANGRIX INC. Class A Ordinary Shares as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.